ABINGDON, England, May 9, 2018 /PRNewswire/ -- NeuroproteXeon announced today that they have completed a distribution agreement with Linde AG (Lin.de) for XENEX™ (xenon by inhalation) for Post Cardiac Arrest Syndrome ("PCAS") for the European Union plus United Kingdom, Switzerland, Norway...
from PR Newswire: //https://ift.tt/2I6tpnb
No comments:
Post a Comment